3-Bromopyruvate inhibits human gastric cancer tumor growth in nude mice via the inhibition of glycolysis (Oncol Lett, 9, (739-744), (2015), 10.3892/ol.2014.2779);3-Bromopyruvate inhibits human gastric cancer tumor growth in nude mice via the inhibition of glycolysis

Oncology Letters

Volumn 9, Issue 2, 2015, Pages 739-744

  Xian, Shu Lin ^a   Cao, Wei ^a   Zhang, Xiao Dong ^a   Lu, Yun Fei ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

3 bromopyruvate; Apoptosis; Hexokinase; Nude mouse; Treatment

Indexed keywords

3 BROMOPYRUVATE; ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINEOPLASTIC AGENT; CASPASE 3; FLUOROURACIL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; HEXOKINASE; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN BAX; PROTEIN BCL 2; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD TOXICITY; CANCER INHIBITION; CELL PROLIFERATION ASSAY; CHROMATIN; CONTROLLED STUDY; DOWN REGULATION; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GASTRIC CANCER CELL LINE; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIVER TOXICITY; LOW DRUG DOSE; MOUSE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; STOMACH CANCER; THROMBOCYTE COUNT; TRANSMISSION ELECTRON MICROSCOPY; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

EID: 84918805394     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.5370     Document Type: Erratum

References (27)

1. Yamamoto M, Sakaguchi Y, Matsuyama A, Yoshinaga K, Tsutsui S and Ishida T: Surgery after preoperative chemotherapy for patients with unresectable advanced gastric cancer. Oncology 85: 241-247, 2013.
2. Qiu HB, Zhang LY, Keshari RP, Wang GQ, Zhou ZW, Xu DZ, Wang W, Zhan YQ and Li W: Relationship between H. Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer 10: 374, 2010.
3. Lu Y, Zhang X, Zhang H, Lan J, Huang G, Varin E, Lincet H, Poulain L and Icard P: Citrate induces apoptotic cell death: a promising way for treating gastric carcinoma? Anticancer Res 31: 797-805, 2011.
4. Grosse J, Warnke E, Wehland M, Pietsch J, Pohl F, Wise P, Magnusson NE, Eilles C and Grimm D: Mechanisms of apoptosis in irradiated and sunitinib-treated follicular thyroid cancer cells. Apoptosis 19: 480-490, 2014.
5. Tokumoto M, Lee JY, Fujiwara Y, Uchiyama M and Satoh M: Inorganic arsenic induces apoptosis through downregulation of Ube2d genes and p53 accumulation in rat proximal tubular cells. J Toxicol Sci 38: 815-820, 2013.
6. Nguyen QD, Lavdas I, Gubbins J, Smith G, Fortt R, Carroll LS, Graham MA and Aboagye EO: Temporal and spatial evolution of therapy-induced tumor apoptosis detected by caspase-3-selective molecular imaging. Clin Cancer Res 19: 3914-3924, 2013.
7. Rahman KM, Banerjee S, Ali S, Ahmad A, Wang Z, Kong D and Sakr WA: 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Res 69: 4468-4475, 2009.
8. Liu L, Gong L, Zhang Y and Li N: Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus. Exp Ther Med 5: 338-342, 2013.
9. Khatri S, Yepiskoposyan H, Gallo CA, Tandon P and Plas DR: FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. J Biol Chem 285: 15960-15965, 2010.
10. Floridi A, Paggi MG and Fanciulli M: Modulation of glycolysis in neuroepithelial tumors. J Neurosurg Sci 33: 55-64, 1989.
11. Nwagwu M and Opperdoes FR: Regulation of glycolysis in Trypanosoma brucei: hexokinase and phosphofructokinase activity. Acta Trop 39: 61-72, 1982.
12. El Sayed SM, Mahmoud AA, El Sawy SA, Abdelaal EA, Fouad AM, Yousif RS, Hashim MS, Hemdan SB, Kadry ZM, Abdelmoaty MA, Gabr AG, Omran FM, Nabo MM and Ahmed NS: Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect). Med Hypotheses 81: 866-870, 2013.
13. Cardaci S, Desideri E and Ciriolo MR: Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug. J Bioenerg Biomembr 44: 17-29, 2012.
14. Ganapathy-Kanniappan S, Vali M, Kunjithapatham R, Buijs M, Syed LH, Rao PP, Ota S, Kwak BK, Loffroy R and Geschwind JF: 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy. Curr Pharm Biotechnol 11: 510-517, 2010.
15. Xian SL, Wei C and Lu YF: 3-BrPA inhibits proliferation of human gastric cancer cell. Chin Pract Med J 12: 78-82, 2013 (In Chinese).
16. Geschwind JF, Ko YH, Torbenson MS, Magee C and Pedersen PL: Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res 62: 3909-3913, 2002.
17. Liapi E and Geschwind JF: Interventional oncology: new options for interstitial treatments and intravascular approaches: targeting tumor metabolism via a loco-regional approach: a new therapy against liver cancer. J Hepatobiliary Pancreat Sci 17: 405-406, 2010.
18. Liu XH, Zheng XF and Wang YL: Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction. Chin Med J (Engl) 122: 1681-1685, 2009.
19. Ota S, Geschwind JF, Buijs M, Wijlemans JW, Kwak BK and Ganapathy-Kanniappan S: Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer. Target Oncol 8: 145-151, 2013.
20. Xu J, Wang J, Xu B, Ge H, Zhou X and Fang JY: Colorectal cancer cells refractory to anti-VEGF treatment are vulnerable to glycolytic blockade due to persistent impairment of mitochondria. Mol Cancer Ther 12: 717-724, 2013.
21. Danial NN, Gramm CF, Scorrano L, et al: BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424: 952-956, 2003.
22. Nelson K: 3-Bromopyruvate kills cancer cells in animals. Lancet Oncol 3: 524, 2002.
23. Cali U, Cavkaytar S, Sirvan L and Danisman N: Placental apoptosis in preeclampsia, intrauterine growth retardation, and HELLP syndrome: an immunohistochemical study with caspase-3 and bcl-2. Clin Exp Obstet Gynecol 40: 45-48, 2013.
24. Han CR, Jun do Y, Lee JY and Kim YH: Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells. Apoptosis 19: 224-240, 2014.
25. Doudican N, Rodriguez A, Osman I and Orlow SJ: Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol Cancer Res 6: 1308-1315, 2008.
26. Deyhimi P and Tavakoli P: Study of apoptosis in oral pemphigus vulgaris using immunohistochemical marker Bax and TUNEL technique. J Oral Pathol Med 42: 409-414, 2013.
27. Banadyga L, Veugelers K, Campbell S and Barry M: The fowlpox virus BCL-2 homologue, FPV039, interacts with activated Bax and a discrete subset of BH3-only proteins to inhibit apoptosis. J Virol 83: 7085-7098, 2009.